NCT05541835

Brief Summary

the aim of the study is to determine Hematological abnormalities in Congenital Cyanotic Heart Disease

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 15, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

March 20, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2023

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

June 25, 2022

Last Update Submit

March 29, 2023

Conditions

Hematologic Diseases

Outcome Measures

Primary Outcomes (1)

  • Hematological Abnormalities In ChilCongenital congenital Cyanotic Heart Disease

    Determine hematological abnormality

    Baseline

Secondary Outcomes (1)

  • Children with Congenital Cyanotic Heart Disease

    Baseline

Interventions

samplingDIAGNOSTIC_TEST

venous sampling of patient

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All childern with Cyanotic Congenital heart disease admitted to the pediatric cardiology unit of Assiut University Hospitals over a period of one year

You may qualify if:

  • All children.
  • congenital cyanotic heart disease

You may not qualify if:

  • other congenital heart disease.
  • other congenital anomalies.
  • other chronic disease.
  • post-operative patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hematologic Diseases

Condition Hierarchy (Ancestors)

Hemic and Lymphatic Diseases

Central Study Contacts

mamoud abdelshkour, master

CONTACT

01140062035midoabdelshakour321@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Hematological Abnormalities In Childern With Congenital Cyanotic Heart Disease Attending Assiut University Hospitals: A Prospective Hospital- Based Study

Study Record Dates

First Submitted

June 25, 2022

First Posted

September 15, 2022

Study Start

March 20, 2023

Primary Completion

November 20, 2023

Study Completion

December 20, 2023

Last Updated

March 31, 2023

Record last verified: 2023-03